Free Trial
ASX:MVP

Medical Developments International (MVP) Stock Price, News & Analysis

Medical Developments International logo

About Medical Developments International Stock (ASX:MVP)

Advanced Chart
Remove Ads

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
169,499 shs
Average Volume
N/A
Market Capitalization
$98.01 million
P/E Ratio
N/A
Dividend Yield
0.77%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers respiratory devices for sufferers of asthma and chronic obstructive pulmonary disease (COPD); and Penthrox, a trauma and emergency pain relief product; and medical devices. The company also provides asthma and COPD products, such as space chambers and silicone face masks. The company was founded in 1971 and is headquartered in Scoresby, Australia.

Remove Ads
Receive MVP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medical Developments International and its competitors with MarketBeat's FREE daily newsletter.

MVP Stock News Headlines

Trump to unlock 15-figure fortune for America (May 3rd) ?
We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America. Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking. And he believes Trump could soon release this frozen asset to the public.
Medical Developments International Limited (MVP.AX)
Medical Developments International Shares Business Outlook
See More Headlines

MVP Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Medical Developments International investors own include Core Lithium (CXO), Bubs Australia (BUB), Talon Energy (TPD), Qantas Airways (QAN), Mesoblast (MESO), LINE (LN) and Harvey Norman (HVN).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
ASX:MVP
CIK
N/A
Fax
N/A
Employees
68
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-40,990,000.00
Net Margins
-123.66%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$33.15 million
Price / Cash Flow
21.37
Book Value
A$0.52 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$98.01 million
Optionable
Not Optionable
Beta
1.63
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (ASX:MVP) was last updated on 4/2/2025 by MarketBeat.com Staff
From Our Partners